Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 175

1.

Molecular mechanism of inhibitory aryl hydrocarbon receptor-estrogen receptor/Sp1 cross talk in breast cancer cells.

Khan S, Barhoumi R, Burghardt R, Liu S, Kim K, Safe S.

Mol Endocrinol. 2006 Sep;20(9):2199-214. Epub 2006 May 4.

PMID:
16675542
2.

Estrogen receptor/Sp1 complexes are required for induction of cad gene expression by 17beta-estradiol in breast cancer cells.

Khan S, Abdelrahim M, Samudio I, Safe S.

Endocrinology. 2003 Jun;144(6):2325-35.

PMID:
12746293
4.

Dioxin and estrogen signaling in lung adenocarcinoma cells with different aryl hydrocarbon receptor/estrogen receptor α phenotypes.

Kuo LC, Cheng LC, Lin CJ, Li LA.

Am J Respir Cell Mol Biol. 2013 Dec;49(6):1064-73. doi: 10.1165/rcmb.2012-0497OC.

5.

The aryl hydrocarbon receptor interacts with estrogen receptor alpha and orphan receptors COUP-TFI and ERRalpha1.

Klinge CM, Kaur K, Swanson HI.

Arch Biochem Biophys. 2000 Jan 1;373(1):163-74.

PMID:
10620335
6.

Estrogen receptor subtype- and promoter-specific modulation of aryl hydrocarbon receptor-dependent transcription.

Wihlén B, Ahmed S, Inzunza J, Matthews J.

Mol Cancer Res. 2009 Jun;7(6):977-86. doi: 10.1158/1541-7786.MCR-08-0396. Epub 2009 May 26.

7.

The aryl hydrocarbon receptor (AHR)/AHR nuclear translocator (ARNT) heterodimer interacts with naturally occurring estrogen response elements.

Klinge CM, Bowers JL, Kulakosky PC, Kamboj KK, Swanson HI.

Mol Cell Endocrinol. 1999 Nov 25;157(1-2):105-19.

PMID:
10619402
8.

The aryl hydrocarbon receptor mediates degradation of estrogen receptor alpha through activation of proteasomes.

Wormke M, Stoner M, Saville B, Walker K, Abdelrahim M, Burghardt R, Safe S.

Mol Cell Biol. 2003 Mar;23(6):1843-55.

9.
10.
11.
12.

The aryl hydrocarbon receptor and estrogen receptor alpha differentially modulate nuclear factor erythroid-2-related factor 2 transactivation in MCF-7 breast cancer cells.

Lo R, Matthews J.

Toxicol Appl Pharmacol. 2013 Jul 15;270(2):139-48. doi: 10.1016/j.taap.2013.03.029. Epub 2013 Apr 11.

PMID:
23583297
13.

Aryl hydrocarbon receptor-independent activation of estrogen receptor-dependent transcription by 3-methylcholanthrene.

Shipley JM, Waxman DJ.

Toxicol Appl Pharmacol. 2006 Jun 1;213(2):87-97. Epub 2005 Oct 27.

PMID:
16257430
14.
15.

Aryl hydrocarbon receptor-mediated inhibition of LNCaP prostate cancer cell growth and hormone-induced transactivation.

Morrow D, Qin C, Smith R 3rd, Safe S.

J Steroid Biochem Mol Biol. 2004 Jan;88(1):27-36.

PMID:
15026081
16.

Cobaltous chloride and hypoxia inhibit aryl hydrocarbon receptor-mediated responses in breast cancer cells.

Khan S, Liu S, Stoner M, Safe S.

Toxicol Appl Pharmacol. 2007 Aug 15;223(1):28-38. Epub 2007 May 25.

17.
18.

Role of specificity protein transcription factors in estrogen-induced gene expression in MCF-7 breast cancer cells.

Khan S, Wu F, Liu S, Wu Q, Safe S.

J Mol Endocrinol. 2007 Oct;39(4):289-304.

PMID:
17909268
19.

The ligand status of the aromatic hydrocarbon receptor modulates transcriptional activation of BRCA-1 promoter by estrogen.

Hockings JK, Thorne PA, Kemp MQ, Morgan SS, Selmin O, Romagnolo DF.

Cancer Res. 2006 Feb 15;66(4):2224-32.

20.

Supplemental Content

Support Center